Yungjin Pharm Co Ltd - Asset Resilience Ratio

Latest as of September 2024: 4.23%

Yungjin Pharm Co Ltd (003520) has an Asset Resilience Ratio of 4.23% as of September 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

₩10.00 Billion

≈ $6.78 Million USD Cash + Short-term Investments

Total Assets

₩236.18 Billion

≈ $160.05 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2023)

This chart shows how Yungjin Pharm Co Ltd's Asset Resilience Ratio has changed over time. Check 003520 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Yungjin Pharm Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 003520 market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩10.00 Billion	4.23%
Total Liquid Assets	₩10.00 Billion	4.23%

Asset Resilience Insights

Limited Liquidity: Yungjin Pharm Co Ltd maintains only 4.23% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Yungjin Pharm Co Ltd Industry Peers by Asset Resilience Ratio

Compare Yungjin Pharm Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Suven Pharmaceuticals Limited NSE:SUVENPHAR	Drug Manufacturers - Specialty & Generic	6.76%
Neuland Laboratories Limited NSE:NEULANDLAB	Drug Manufacturers - Specialty & Generic	9.65%
Bausch Health Companies Inc TO:BHC	Drug Manufacturers - Specialty & Generic	4.97%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	48.48%
Changzhou Qianhong Biopharma Co Ltd SHE:002550	Drug Manufacturers - Specialty & Generic	18.70%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%
Shandong Lukang Pharmaceutical Co Ltd SHG:600789	Drug Manufacturers - Specialty & Generic	0.01%
Heilongjiang ZBD Pharmaceutical Co Ltd SHG:603567	Drug Manufacturers - Specialty & Generic	0.00%

Annual Asset Resilience Ratio for Yungjin Pharm Co Ltd (2014–2023)

The table below shows the annual Asset Resilience Ratio data for Yungjin Pharm Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	1.32%	₩3.00 Billion ≈ $2.03 Million	₩226.60 Billion ≈ $153.56 Million	-2.60pp
2017-12-31	3.92%	₩8.00 Billion ≈ $5.42 Million	₩203.85 Billion ≈ $138.14 Million	+3.80pp
2016-12-31	0.12%	₩240.00 Million ≈ $162.64K	₩199.35 Billion ≈ $135.10 Million	-0.67pp
2014-12-31	0.79%	₩1.41 Billion ≈ $955.54K	₩178.97 Billion ≈ $121.28 Million	--

pp = percentage points

About Yungjin Pharm Co Ltd

KO:003520 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$152.08 Million

₩224.41 Billion KRW

Market Cap Rank

#17619 Global

#722 in Korea

Share Price

₩1227.00

Change (1 day)

+0.57%

52-Week Range

₩1105.00 - ₩2170.00

All Time High

₩17500.00